Brain Tumor Detected During Routine Eye Test Highlights Importance of Preventative Healthcare
A Northampton woman, Gemma Hillier, 45, discovered a grade 2 meningioma brain tumor during a routine eye test in September 2023 after experiencing vision problems, highlighting the importance of regular eye check-ups for early detection of such conditions. Surgery removed 90 percent of the tumor in ...
Brain Tumor Detected During Routine Eye Test Highlights Importance of Preventative Healthcare
A Northampton woman, Gemma Hillier, 45, discovered a grade 2 meningioma brain tumor during a routine eye test in September 2023 after experiencing vision problems, highlighting the importance of regular eye check-ups for early detection of such conditions. Surgery removed 90 percent of the tumor in ...
Progress
36% Bias Score
Oral Microbiome Test Predicts Heart Disease, Cancer, and Dementia Risks
A new £350 test, ORALIS 1, analyzes mouth bacteria to predict risks of heart disease, cancer, and dementia; one patient with alarmingly high levels of fusobacterium nucleatum highlights its potential for early disease detection and prevention.
Oral Microbiome Test Predicts Heart Disease, Cancer, and Dementia Risks
A new £350 test, ORALIS 1, analyzes mouth bacteria to predict risks of heart disease, cancer, and dementia; one patient with alarmingly high levels of fusobacterium nucleatum highlights its potential for early disease detection and prevention.
Progress
40% Bias Score
Colorectal Cancer: Early Detection is Key
Colorectal cancer, the third most common cancer globally, often presents asymptomatically initially, highlighting the importance of regular screening through colonoscopy, starting at age 40-45, for early detection and polyp removal to prevent malignant transformation.
Colorectal Cancer: Early Detection is Key
Colorectal cancer, the third most common cancer globally, often presents asymptomatically initially, highlighting the importance of regular screening through colonoscopy, starting at age 40-45, for early detection and polyp removal to prevent malignant transformation.
Progress
48% Bias Score
Two Simple Questions Accurately Identify Alcohol Dependence
A 2014 University of Leicester study found that two simple questions accurately identify alcohol dependence in 87% of cases, targeting both binge drinking and alcohol use for stress relief; the study's findings have implications for early detection and treatment of alcohol-related disorders.
Two Simple Questions Accurately Identify Alcohol Dependence
A 2014 University of Leicester study found that two simple questions accurately identify alcohol dependence in 87% of cases, targeting both binge drinking and alcohol use for stress relief; the study's findings have implications for early detection and treatment of alcohol-related disorders.
Progress
52% Bias Score
MOBO Awards Founder Diagnosed with Stage Four Bowel Cancer
Kanya King, founder of the MOBO Awards, announced her stage four bowel cancer diagnosis, using her platform to advocate for early detection and proactive healthcare while continuing to lead the organization.
MOBO Awards Founder Diagnosed with Stage Four Bowel Cancer
Kanya King, founder of the MOBO Awards, announced her stage four bowel cancer diagnosis, using her platform to advocate for early detection and proactive healthcare while continuing to lead the organization.
Progress
16% Bias Score
USPSTF Recommends HPV Testing as Primary Cervical Cancer Screening
The US Preventive Services Task Force (USPSTF) preliminarily recommends high-risk HPV testing every 5 years, including self-collected samples, as the preferred cervical cancer screening strategy for women aged 30-65, prioritizing it over Pap smears due to its superior effectiveness and potential for...
USPSTF Recommends HPV Testing as Primary Cervical Cancer Screening
The US Preventive Services Task Force (USPSTF) preliminarily recommends high-risk HPV testing every 5 years, including self-collected samples, as the preferred cervical cancer screening strategy for women aged 30-65, prioritizing it over Pap smears due to its superior effectiveness and potential for...
Progress
48% Bias Score
Record High in Early-Stage Cancer Diagnoses in England
New data shows a record high number of English cancer patients diagnosed at an early stage, with 58.7% of approximately 206,000 cancer diagnoses between September 2023 and August 2024 being stage one or two; this is 7,000 more than pre-pandemic levels, resulting from intensified cancer screening cam...
Record High in Early-Stage Cancer Diagnoses in England
New data shows a record high number of English cancer patients diagnosed at an early stage, with 58.7% of approximately 206,000 cancer diagnoses between September 2023 and August 2024 being stage one or two; this is 7,000 more than pre-pandemic levels, resulting from intensified cancer screening cam...
Progress
40% Bias Score
AI Blood Tests Show Promise in Early Ovarian Cancer Detection
New AI-powered blood tests are showing promise in detecting ovarian cancer five years before symptoms appear, improving diagnosis and survival rates; AI also speeds up pneumonia diagnosis and antibiotic selection, reducing costs and improving patient care.
AI Blood Tests Show Promise in Early Ovarian Cancer Detection
New AI-powered blood tests are showing promise in detecting ovarian cancer five years before symptoms appear, improving diagnosis and survival rates; AI also speeds up pneumonia diagnosis and antibiotic selection, reducing costs and improving patient care.
Progress
44% Bias Score
Declining Cancer Screening Participation in England Raises Concerns
Cancer screening programs in England detected almost 90,000 cancers (62,000 breast, 23,000 bowel, 4,400 cervical) between 2019 and 2023, but participation rates are declining, particularly for breast (65%) and cervical (69%) cancers, prompting calls for improved access and digital enhancements.
Declining Cancer Screening Participation in England Raises Concerns
Cancer screening programs in England detected almost 90,000 cancers (62,000 breast, 23,000 bowel, 4,400 cervical) between 2019 and 2023, but participation rates are declining, particularly for breast (65%) and cervical (69%) cancers, prompting calls for improved access and digital enhancements.
Progress
36% Bias Score
Ten Early Warning Signs of Cancer: Professor Drapkina's Urgent Warning
Professor Oksana Drapkina lists ten potential early cancer symptoms: unexplained weight loss, fatigue, persistent cough, swallowing difficulties, enlarged lymph nodes, chronic pain, skin changes, digestive issues, urinary problems, and unexplained bleeding; early detection is crucial for successful ...
Ten Early Warning Signs of Cancer: Professor Drapkina's Urgent Warning
Professor Oksana Drapkina lists ten potential early cancer symptoms: unexplained weight loss, fatigue, persistent cough, swallowing difficulties, enlarged lymph nodes, chronic pain, skin changes, digestive issues, urinary problems, and unexplained bleeding; early detection is crucial for successful ...
Progress
36% Bias Score
Laser and AI Blood Test Detects Stage 1a Breast Cancer with 98% Accuracy
A University of Edinburgh team developed a 98% accurate blood test using lasers and AI to detect stage 1a breast cancer, identifying subtle chemical changes undetectable by current methods; it also distinguishes between cancer subtypes with over 90% accuracy.
Laser and AI Blood Test Detects Stage 1a Breast Cancer with 98% Accuracy
A University of Edinburgh team developed a 98% accurate blood test using lasers and AI to detect stage 1a breast cancer, identifying subtle chemical changes undetectable by current methods; it also distinguishes between cancer subtypes with over 90% accuracy.
Progress
48% Bias Score
Eye-Tracking Device Wins Award for Early Neurodevelopmental Disorder Detection
SuriCog's EyeBrain Neo, a device using eye-tracking to detect neurodevelopmental disorders in children, won the 2024 Marcel Dassault Prize; a pilot study will assess its effectiveness in schools starting April 2025.
Eye-Tracking Device Wins Award for Early Neurodevelopmental Disorder Detection
SuriCog's EyeBrain Neo, a device using eye-tracking to detect neurodevelopmental disorders in children, won the 2024 Marcel Dassault Prize; a pilot study will assess its effectiveness in schools starting April 2025.
Progress
32% Bias Score